Although we have not performed methods to determine the tumor-initiating capacities of CD133+ cells in vivo, the importance of CD133 in CSCs has widely been confirmed [49]–[55] As KLF4 plays a key role in the induction and maintenance of stem cells. The gene discussed is PROM1; the disease is neoplasm.